NVIDIA-backed startups develop AI-powered breast cancer screening platform
A new AI-powered breast cancer screening platform is commercially available in several US states, aiming to address the diagnosis gap.
- The breast cancer diagnosis gap is significant, with millions of women not undergoing recommended annual screenings.
- The ATUSA platform, developed by iSono Health, takes only two minutes per breast to capture a standardized volume, compared to up to 45 minutes for handheld ultrasound.
- The ATUSA platform is commercially available in several US states and new sites are being added regularly.
- The development of AI-powered breast cancer screening platforms like ATUSA has the potential to transform the way breast cancer is diagnosed and treated.
- The development of AI-powered breast cancer screening platforms like ATUSA has the potential to significantly improve breast cancer diagnosis and treatment outcomes.
The breast cancer diagnosis gap is significant, with millions of women not undergoing recommended annual screenings. According to the NVIDIA Blog, tens of thousands of women are not receiving the necessary care. This gap is attributed to various factors, including lack of access to healthcare facilities and shortage of skilled healthcare professionals.
AI-powered breast cancer screening platform
The ATUSA platform, developed by iSono Health, takes only two minutes per breast to capture a standardized volume, compared to up to 45 minutes for handheld ultrasound. This reduction in time allows for more efficient and accurate scans. The AI-powered platform uses over 1.5 million ultrasound frames for image acquisition, enabling 3D scan creation. The platform's ability to capture high-quality images in a shorter amount of time is a significant breakthrough. As "getting the scan closer to the patient is the first breakthrough." (NVIDIA Blog), the ATUSA platform has the potential to significantly improve breast cancer diagnosis and treatment outcomes.
Commercial availability and expansion
The ATUSA platform is commercially available in several US states and new sites are being added regularly. This expansion will help address the diagnosis gap by providing more women with access to this technology.
Future prospects and implications
The development of AI-powered breast cancer screening platforms like ATUSA has the potential to transform the way breast cancer is diagnosed and treated. With its ability to capture high-quality images in a shorter amount of time, the ATUSA platform has the potential to improve breast cancer diagnosis and treatment outcomes. Furthermore, the platform's commercial availability and expansion will help address the diagnosis gap and provide more women with access to this technology.
Conclusion
The development of AI-powered breast cancer screening platforms like ATUSA has the potential to significantly improve breast cancer diagnosis and treatment outcomes. With its ability to capture high-quality images in a shorter amount of time, the ATUSA platform has the potential to transform the way breast cancer is diagnosed and treated. tags: breast cancer, AI, healthcare imagePrompt: An illustration of a woman undergoing a breast cancer screening scan, with a 3D image of the scan results in the background.
Sources
Related stories
The Nvidia Shield TV Is 7 Years Old. It Just Got a $100 Price Hike
The era of generative AI has upended technology supply chains, and there is one ironclad rule in 2026: If it has memory or storage, it’s getting more expensive. Even devices with years-old tech inside are still apparently subject to that unwritten rule.
Productive, Durable, Fungible: How NVIDIA AI Factories Maximize Return on Investment
AI factories are built by the megawatt, even by the gigawatt. Each megawatt factory costs roughly $60 million, and AI factory operators will only commit…
Deploying an HSTU Generative Recommender with NVIDIA Dynamo-Triton
Deploying an HSTU Generative Recommender with NVIDIA Dynamo-Triton | NVIDIA Technical Blog Deploying an HSTU Generative Recommender with NVIDIA Dynamo-Triton By Junyi Qiu , Shijie Liu , J Wyman and Mudit Aggarwal Generative recommender systems reformulate personalization as sequence modeling over user behavior, and NVIDIA recsys-examples now provides an end-to-end HSTU inference workflow with Dynamo-Triton.
Tracing Agent Harness Behavior with NVIDIA NeMo Relay
Tracing Agent Harness Behavior with NVIDIA NeMo Relay | NVIDIA Technical Blog Tracing Agent Harness Behavior with NVIDIA NeMo Relay Learn how to use execution traces to understand agent behavior and determine whether harness changes improve task outcomes.